GB2292887B - Drug delivery system - Google Patents
Drug delivery systemInfo
- Publication number
- GB2292887B GB2292887B GB9523475A GB9523475A GB2292887B GB 2292887 B GB2292887 B GB 2292887B GB 9523475 A GB9523475 A GB 9523475A GB 9523475 A GB9523475 A GB 9523475A GB 2292887 B GB2292887 B GB 2292887B
- Authority
- GB
- United Kingdom
- Prior art keywords
- delivery system
- drug delivery
- drug
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9523475A GB2292887B (en) | 1993-04-16 | 1994-04-15 | Drug delivery system |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939307904A GB9307904D0 (en) | 1993-04-16 | 1993-04-16 | Drug delivery system |
GB939324682A GB9324682D0 (en) | 1993-12-01 | 1993-12-01 | Drug delivery system |
PCT/GB1994/000806 WO1994023752A1 (en) | 1993-04-16 | 1994-04-15 | Drug delivery system |
GB9523475A GB2292887B (en) | 1993-04-16 | 1994-04-15 | Drug delivery system |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9523475D0 GB9523475D0 (en) | 1996-01-17 |
GB2292887A GB2292887A (en) | 1996-03-13 |
GB2292887B true GB2292887B (en) | 1997-05-07 |
Family
ID=26302771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9523475A Expired - Fee Related GB2292887B (en) | 1993-04-16 | 1994-04-15 | Drug delivery system |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6510094A (en) |
GB (1) | GB2292887B (en) |
WO (1) | WO1994023752A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020001600A1 (en) * | 1995-05-30 | 2002-01-03 | Michael J. Oldham | Method of using lectins for prevention and treatment of skin diseases and disorders |
JPH11510164A (en) * | 1995-07-26 | 1999-09-07 | マキシム ファーマシューティカルズ | Mucosal delivery of polynucleotides |
GB0213383D0 (en) * | 2002-06-11 | 2002-07-24 | Cambridge Biotechnology Ltd | Therapeutic conditions |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993000076A1 (en) * | 1991-06-24 | 1993-01-07 | Minnesota Mining And Manufacturing Company | Carrier systems for drugs |
-
1994
- 1994-04-15 AU AU65100/94A patent/AU6510094A/en not_active Abandoned
- 1994-04-15 GB GB9523475A patent/GB2292887B/en not_active Expired - Fee Related
- 1994-04-15 WO PCT/GB1994/000806 patent/WO1994023752A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993000076A1 (en) * | 1991-06-24 | 1993-01-07 | Minnesota Mining And Manufacturing Company | Carrier systems for drugs |
Also Published As
Publication number | Publication date |
---|---|
WO1994023752A1 (en) | 1994-10-27 |
GB2292887A (en) | 1996-03-13 |
GB9523475D0 (en) | 1996-01-17 |
AU6510094A (en) | 1994-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU664807B2 (en) | Drug delivery system | |
EP0662851A4 (en) | Drug delivery system. | |
EP0707471A4 (en) | Novel therapeutic drug delivery systems | |
AU4989993A (en) | Drug delivery system | |
EP0802788A4 (en) | Novel therapeutic delivery systems | |
GB9218852D0 (en) | Drug dispensing system | |
AU3050892A (en) | Delivery system | |
AU4505496A (en) | Sustained-release drug delivery system | |
AU6534894A (en) | Drug administration system | |
EG20670A (en) | Active substance delivery system | |
EP0989878A4 (en) | Drug delivery system | |
AU660290B2 (en) | Multiple drug delivery system | |
ZA937164B (en) | Delivery system | |
EP1021137A4 (en) | Drug delivery system | |
GB9325330D0 (en) | Fluorocyclodextrin drug delivery system | |
EP0913159A4 (en) | Drug delivery system using galactoxyloglucan | |
GB2275123B (en) | Drug dispensing system | |
GB9404293D0 (en) | Drug delivery system | |
GB2292887B (en) | Drug delivery system | |
EP0636363A3 (en) | Drug delivery system. | |
GB9617607D0 (en) | Infusate delivery system | |
GB9303117D0 (en) | Drug delivery system | |
GB9307904D0 (en) | Drug delivery system | |
GB9324682D0 (en) | Drug delivery system | |
GB9306615D0 (en) | Novel drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20080415 |